Perry Jennifer Scott sold $6K of BCYC
Perry Jennifer Scott (Chief Operating Officer) sold 1,412 shares of BICYCLE THERAPEUTICS PLC (BCYC) at an average of $4.29 ($4.27–$4.34) across 3 trades over 2026-07-02 to 2026-07-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Insider sales can influence sentiment, but 10b5-1 pre-arranged selling and the modest transaction value reduce the likelihood of a durable price reaction.
Market read
Traders may note the disclosure for sentiment monitoring, but it does not introduce new fundamentals or a time-critical corporate event.
What to watch
The article provides only the sale details; without concurrent buys, guidance, trial updates, or financing news, the trading signal is weak.
Background
The article is a SEC Form 4 insider transaction disclosure for Bicycle Therapeutics PLC (BCYC).
Ticker impact
Bicycle Therapeutics COO Perry Jennifer Scott sold $6,054 of BCYC shares in open-market trades under a 10b5-1 plan (Form 4 filed July 7).
Low near-term impact; any effect is likely short-lived unless paired with other new company-specific catalysts.
The filing is an insider transaction (S sale) with a pre-arranged 10b5-1 plan and small dollar value, providing disclosure but not a new operating or financial datapoint.
Market effects
Minimal—single-company insider sale with no sector-wide regulatory/clinical/financial update.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect liquidity needs rather than negative expectations; traders may discount it.
Key entities
- issuerBicycle Therapeutics PLC
Subject of the Form 4 insider transaction disclosure.
- insiderPerry Jennifer Scott
Chief Operating Officer who sold shares in open-market transactions.
- trading mechanism10b5-1 plan
Pre-arranged plan indicating the trades were scheduled in advance.